MYC and breast carcinoma: The mechanistic exploration revealed that PAX7 influences breast cancer through the Wnt/β‐catenin signalling pathway, resulting in reduced expression of β‐catenin, c‐MYC, and Cyclin D1 when PAX7 is suppressed.